Literature DB >> 92380

Demonstration of two disease specific antigens in circulating immune complexes.

C Dambuyant, J Burton-Kee, J F Mowbray.   

Abstract

A method is described to assess antigenic cross-reactivity between soluble immune complexes precipitated from sera with polyethylene glycol. The precipitated complex from one serum was dissociated in acid and used to coat a plastic cup. Radioiodinated complexes from another serum were dissociated in the cup, neutralized and allowed to reassociate overnight. The binding of the labelled complex was used to measure the cross-reactivity between the complexes. Using this technique, complexes from a group of patients with haematuria and hypertension have been found to share an antigen, and a different antigen was found in patients with bullous pemphigoid. The participation of rheumatoid factors in the cross-reactions is unlikely, and no cross-reactivity of either group was found with sera from patients with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92380      PMCID: PMC1537766     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin.

Authors:  M B Oldstone
Journal:  Prog Med Virol       Date:  1975

2.  Detection of hepatitis B antigen in circulating immune complexes in acute and chronic hepatitis.

Authors:  G Carella; M Digeon; G Feldmann; P Jungers; J Drouet; J F Bach
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

3.  Basement zone antibodies in bullous pemphigoid.

Authors:  R E Jordon; E H Beutner; E Witebsky; G Blumental; W L Hale; W F Lever
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

4.  Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane.

Authors:  B Combes; J Shorey; A Barrera; P Stastny; E H Eigenbrodt; A R Hull; N W Carter
Journal:  Lancet       Date:  1971-07-31       Impact factor: 79.321

5.  IgA glomerular deposits in renal disease.

Authors:  J Berger
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

6.  The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.

Authors:  P J Lachmann
Journal:  Immunochemistry       Date:  1971-01

7.  Association between polyarteritis and Australia antigen.

Authors:  D J Gocke; K Hsu; C Morgan; S Bombardieri; M Lockshin; C L Christian
Journal:  Lancet       Date:  1970-12-05       Impact factor: 79.321

8.  Acute poststreptococcal glomerulonephritis: immune deposit disease.

Authors:  A F Michael; K N Drummond; R A Good; R L Vernier
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

9.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

Authors:  J R Wands; E Mann; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

10.  The use of the preparation of F(ab')2 antibody from soluble immune complexes to determine the complexed antigens.

Authors:  C Dambuyant; J Burton-Kee; J F Mowbray
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

View more
  8 in total

1.  Detection of specific antigen within circulating immune complexes: validation of the assay and its application to food antigen-antibody complexes formed in healthy and food-allergic subjects.

Authors:  R Paganelli; R J Levinsky; D J Atherton
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

2.  Intestinal absorption of food antigens in coeliac disease.

Authors:  R W Pitcher-Wilmott; I Booth; J Harries; R J Levinsky
Journal:  Arch Dis Child       Date:  1982-06       Impact factor: 3.791

3.  Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.

Authors:  C Bruneau; H Bonin
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  Circulating immune complexes in tuberculosis.

Authors:  N M Johnson; M W McNicol; E J Burton-Kee; J F Mowbray
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

5.  Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.

Authors:  G Valesini; M Picardo; R Pastore; P Pivetti; U Serafini
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

6.  Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.

Authors:  R W Pitcher-Wilmott; R J Levinsky; D J Matthew
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

7.  Circulating immune complexes in patients with usual interstitial pulmonary fibrosis: partial characterization and relationship with Thermoactinomyces vulgaris.

Authors:  R Cocchiara; A Giallongo; S Amoroso; G Spina; R Stancampiano; D Geraci
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

8.  Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.

Authors:  M D Kazatchkine; Y Sultan; E J Burton-Kee; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.